Medical technology company Carl Zeiss Meditec AG (CZMWF.PK) posted a 18.7 percent year-on-year growth in full-year earnings before interest and tax or EBIT to 122.9 million euros, with all regions and strategic business units contributing to this growth. Earnings per share for the recent year were 0.88 euros, higher than last year's 0.82 euros.
Annual revenue climbed 13.6 percent to 861.9 million euros, from 758.8 million euros a year ago, thereby slightly exceeding the upper limit of the revenue forecast.
Looking forward, the company said it is well on its way to achieving its EBIT margin target of 15 percent by 2015. As announced, the Supervisory Board and Management Board shall propose to the Annual General Meeting a dividend of 0.40 euros per share for fiscal year 2011/2012.
For comments and feedback: editorial@rttnews.com